Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
23.32
-0.02 (-0.09%)
Dec 5, 2025, 3:00 PM CST
Yifeng Pharmacy Chain Revenue
Yifeng Pharmacy Chain had revenue of 5.56B CNY in the quarter ending September 30, 2025, with 1.97% growth. This brings the company's revenue in the last twelve months to 24.13B, up 0.88% year-over-year. In the year 2024, Yifeng Pharmacy Chain had annual revenue of 24.06B with 6.53% growth.
Revenue (ttm)
24.13B
Revenue Growth
+0.88%
P/S Ratio
1.17
Revenue / Employee
602.96K
Employees
40,018
Market Cap
28.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24.06B | 1.47B | 6.53% |
| Dec 31, 2023 | 22.59B | 2.70B | 13.59% |
| Dec 31, 2022 | 19.89B | 4.56B | 29.75% |
| Dec 31, 2021 | 15.33B | 2.18B | 16.60% |
| Dec 31, 2020 | 13.14B | 2.87B | 27.91% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |